GREY:ATBPF - Post by User
Comment by
Actuarialon May 17, 2021 9:32am
184 Views
Post# 33213195
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share price taken down
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Share price taken downAgreed. Makeing a deal before P3 is preferred but it is never a promise nor a sure thing to happen. Negatiation doesn't alway result in a deal because of a lot of things, one of them is price. The only thing so far we have confidence is the science of H2S platform. ATE has enough cash to take 346 through P3 alone even in the worst scenario. Other scenarios can only be better. Nothing truly to worry about. GLTA longs!
MrMugsy wrote: Yellowknifer69 wrote: Hello and good morning ATE Longs:
Hope all are well and staying Covid-Free. To the point about heading into P3, I thought I read something from Dan indicating that the Company had no intention of actually starting the clinical trials. That something would likely transpire well before that time? Can anybody clarify?
With thanks,
Staying long, no place else to go - literally! Lol
Yellowknifer
True - they don't want to take OTENA to P3 on their own.
That comment came from Dan years ago - before being fully funded - and it's been echoed by the company since.
I'm sure they would like to strike a deal sooner than later - or a deal in principal - or even a conditional deal ... but ... this is still very fluid and evloving (IMO only).
I don't think they can promise anything as I'm assuming discussions are ongoing - and - they haven't talked to all potential partners yet.